171 related articles for article (PubMed ID: 7541638)
1. Deletion mapping of chromosome 11 in carcinoma of the bladder.
Shaw ME; Knowles MA
Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
[TBL] [Abstract][Full Text] [Related]
2. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
3. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.
Shipman R; Schraml P; Colombi M; Raefle G; Ludwig CU
Hum Genet; 1993 Jun; 91(5):455-8. PubMed ID: 8100210
[TBL] [Abstract][Full Text] [Related]
5. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
[TBL] [Abstract][Full Text] [Related]
6. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
7. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Genes Chromosomes Cancer; 1994 Jul; 10(3):183-9. PubMed ID: 7522041
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
9. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
10. Definition of a region of loss of heterozygosity at chromosome 11q in cervical carcinoma.
Mugica-Van Herckenrode C; Rodriguez JA; Iriarte-Campo V; Carracedo A; Barros F
Diagn Mol Pathol; 1999 Jun; 8(2):92-6. PubMed ID: 10475383
[TBL] [Abstract][Full Text] [Related]
11. Allelotype of neuroblastoma.
Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
[TBL] [Abstract][Full Text] [Related]
12. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
Koreth J; Bakkenist CJ; McGee JO
Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 11q22-q23 in breast cancer.
Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
Viel A; Giannini F; Tumiotto L; Sopracordevole F; Visentin MC; Boiocchi M
Br J Cancer; 1992 Dec; 66(6):1030-6. PubMed ID: 1360809
[TBL] [Abstract][Full Text] [Related]
15. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
Keen AJ; Knowles MA
Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555
[TBL] [Abstract][Full Text] [Related]
16. Allelotype of human bladder cancer.
Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
[TBL] [Abstract][Full Text] [Related]
17. Allele loss on chromosome 11q and microsatellite instability in malignant melanoma.
Tomlinson IP; Beck NE; Bodmer WF
Eur J Cancer; 1996 Sep; 32A(10):1797-802. PubMed ID: 8983292
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
[TBL] [Abstract][Full Text] [Related]
19. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation.
Eubanks PJ; Sawicki MP; Samara GJ; Gatti R; Nakamura Y; Tsao D; Johnson C; Hurwitz M; Wan YJ; Passaro E
Am J Surg; 1994 Jan; 167(1):180-5. PubMed ID: 7906100
[TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer.
Dahiya R; McCarville J; Lee C; Hu W; Kaur G; Carroll P; Deng G
Int J Cancer; 1997 Jul; 72(2):283-8. PubMed ID: 9219834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
